Quest Diagnostics Overview
- Founded
-
1967
- Status
-
Public
- Employees
-
49,000
- Stock Symbol
-
DGX
- Investments
-
65
- Share Price
-
$148.64
- (As of Wednesday Closing)
Quest Diagnostics General Information
Description
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Contact Information
Website
www.questdiagnostics.com
Formerly Known As
Corning Clinical Laboratories, Metropolitan Pathology Laboratory
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Stock Exchange
NYS
Primary Office
- 500 Plaza Drive
- Secaucus, NJ 07094
- United States
+1 (800) 000-0000
Quest Diagnostics Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $148.64 | $148.48 | $120.40 - $158.34 | $16.9B | 114M | 1.08M | $10.36 |
Quest Diagnostics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 18,269,426 | 25,005,962 | 19,730,062 | 18,620,302 |
| Revenue | 10,294,000 | 10,788,000 | 9,437,000 | 7,726,000 |
| EBITDA | 2,198,000 | 3,158,000 | 2,408,000 | 1,580,000 |
| Net Income | 1,235,000 | 1,995,000 | 1,431,000 | 858,000 |
| Total Assets | 13,223,000 | 13,611,000 | 14,026,000 | 12,843,000 |
| Total Debt | 4,640,000 | 4,773,000 | 4,808,000 | 5,416,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Quest Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quest Diagnostics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The com
Laboratory Services (Healthcare)
Secaucus, NJ
49,000
As of 2021
000000 - 000
000000
x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000000000 00000000
Burlington, NC
00000
As of 0000
00000000000
000000
cing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000 00000000
Nottingham, United Kingdom
0
As of 0000
000.00
00000000000
000.00
Add Comparison
Quest Diagnostics Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Laboratory Corporation of America | Corporation | Burlington, NC | 00000 | 00000000000 | ||
| 000000 0000000000 | Formerly PE-Backed | Nottingham, United Kingdom | 0 | 000.00 | 00000000000 | 000.00 |
| 00000000000 000000 | Formerly PE-Backed | Houston, TX | 000000000 - | |||
| 000000 00000000 00 | Corporation | CA | 00 | |||
| 000000 00000 00000 | Corporate Backed or Acquired | Tempe, AZ | 0000 | 0000000000 0 |
Quest Diagnostics Patents
Quest Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220299524-A1 | Identification and quantitation of insulin-like growth factor-i variants by mass spectrometry | Pending | 19-Mar-2021 | 00000000000 | |
| EP-4104108-A1 | Extraction of relevant signals from sparse data sets | Pending | 13-Feb-2020 | 000000000 | |
| CA-3167609-A1 | Extraction of relevant signals from sparse data sets | Pending | 13-Feb-2020 | 000000000 | |
| CA-3167616-A1 | System for determining an underlying cause of anemia | Pending | 11-Feb-2020 | 0000000000 | |
| EP-4103595-A1 | System for determining an underlying cause of anemia | Pending | 11-Feb-2020 | C07K14/805 |
Quest Diagnostics Executive Team (65)
Quest Diagnostics Board Members (19)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000000 | Self | Board Member, Committee Member of Compensation and Cybersecurity | 000 0000 |
| 0000 00000000 00.0 | Self | Board Member, Chairman of Quality and Compliance and Committee Member of Audit & Finance and Governance | 000 0000 |
| 0000 00000000 | Quest Diagnostics | Board member | 000 0000 |
| 00000 00000 | Quest Diagnostics | Chief Executive Officer, Board Member, Executive Committee Member and President | 000 0000 |
| 0000000 0000000000 | Quest Diagnostics | Chairman and Executive Committee Member | 000 0000 |
Quest Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Quest Diagnostics Investments & Acquisitions (65)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 08-Dec-2022 | 0000000000 | Hospitals/Inpatient Services | 00000 000 | |
| 00000 000000 | 28-Nov-2022 | 000000000 | Laboratory Services (Healthcare) | ||
| 0000 000000 | 01-Feb-2022 | 0000000000 | 00000 | Other Healthcare Services | 0000000 0 |
| 0000000 00000 | 13-Dec-2021 | 0000000000 | 0000 | Laboratory Services (Healthcare) | 0000000 0 |
| Nationwide Laboratory Services | 24-Aug-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | 0000 0000 |
Quest Diagnostics Subsidiaries (16)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Pack Health | Other Healthcare Services | Birmingham, AL | 2013 |
| 000000000 00000000 | Other Healthcare Services | Espoo, Finland | 0000 |
| 0000000 0000000000 | Laboratory Services (Healthcare) | Anderson, SC | 0000 |
| 000 000000 | Laboratory Services (Healthcare) | Lewisville, TX | 0000 |
| 000000000 00000000 | Drug Discovery | Cleveland, OH | 0000 |
Quest Diagnostics ESG
Risk Overview
Risk Rating
Updated December, 23, 2022
20.98 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,638
Rank
00.00
Percentile
Healthcare
Industry
00 of 636
Rank
00.00
Percentile
Medical Services
Subindustry
00 of 115
Rank
00.00
Percentile
Quest Diagnostics Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 | 07-Jun-2019 | 000000000 | Completed |
|
|
| 00000000 000000 | 22-May-2017 | 00000 00000 00 | 0000 | Completed |
|
| 00 000000000 | 31-Mar-2015 | 00000 0000000 | Completed |
|
|
| 000000 000000 | 21-Apr-2014 | 000000000000000000 | Completed |
|
|
| OralDNA Labs | 01-May-2009 | Merger/Acquisition | Completed |